I like the jib of yo sail Jesse. It does seem a bit more complicated than just 50:50.
Another reason why it may be premature in bedding down agreement between DS & Biota is the uncertainty of who funds the LANI prevention trials (US Govt or Biota)... that would impact the final split between DS/Biota.
There are other flu partnerships out there which might give us some guidance.
Permavir - Biocryst/Shinogi (Biocryst being the BARDA recipient) and Favipiravir - Toyoma Chemicals/US partner (US partner being the recipient of DTRA funding).
Wonder what their arrangements are.
- Forums
- ASX - By Stock
- BTA
- Ann: Release of Scheme Booklet
Ann: Release of Scheme Booklet , page-13
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online